Matrix Trust Company’s Medpace MEDP Stock Holding History

Matrix Trust Company’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-28	Closed	-$9K	–	268
2024 Q3	$9K	Hold	28	–	–	﹤0.01%	238
2024 Q2	$12K	Buy	+28	New	+$11.1K	﹤0.01%	143

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Matrix Trust Company's MEDP Position: Q4 2024 in Review

Matrix Trust Company sold out of Medpace (MEDP) in Q4 2024, closing a stake of 28 shares — an estimated $9K sold.

Matrix Trust Company first reported a position in MEDP in Q2 2024 and held it in 2 quarters. The position peaked at $12K in Q2 2024. 592 funds tracked by Wall St. Rank hold MEDP as of Q4 2024.

Matrix Trust Company reported no remaining Medpace position as of Q4 2024 after selling out during the quarter.
Matrix Trust Company sold 28 Medpace shares in Q4 2024, an estimated $9K.
Matrix Trust Company first reported a position in Medpace in Q2 2024 and held it in 2 quarters.
Matrix Trust Company's Medpace position peaked at $12K in Q2 2024.
592 funds tracked by Wall St. Rank held Medpace as of Q4 2024.

Based on Matrix Trust Company's 13F filing for Q4 2024, filed 13 Jan 2025.